about
Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.Directed evolution of adeno-associated virus to an infectious respiratory virusAdeno-associated Virus as a Mammalian DNA VectorRole of capsid proteins in parvoviruses infectionStructure of Adeno-Associated Virus Serotype 8, a Gene Therapy VectorThe structure of adeno-associated virus serotype 3B (AAV-3B): Insights into receptor binding and immune evasionStructural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6Structural Insight into the Unique Properties of Adeno-Associated Virus Serotype 9Structural Insights into Adeno-Associated Virus Serotype 5Structure of neurotropic adeno-associated virus AAVrh.8.Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer.Comparative analysis of adeno-associated virus capsid stability and dynamicsDirected evolution of adeno-associated virus yields enhanced gene delivery vectors.AAV's anatomy: roadmap for optimizing vectors for translational successStructure of adeno-associated virus type 4.Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb.Structural determinants of tissue tropism and in vivo pathogenicity for the parvovirus minute virus of miceHost-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence.Atomic modeling of cryo-electron microscopy reconstructions--joint refinement of model and imaging parameters.AAV hybrid serotypes: improved vectors for gene deliveryRecombinant vectors based on porcine adeno-associated viral serotypes transduce the murine and pig retinaAlpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6Structurally mapping the diverse phenotype of adeno-associated virus serotype 4.The AAV vector toolkit: poised at the clinical crossroadsDifferent mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5Intracellular trafficking of adeno-associated viral vectors.Acquisition of selective antitumoral effects of recombinant adeno-associated virus by genetically inserting tumor-targeting peptides into capsid proteinsPerspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene TherapyProduction, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 1.Surface loop dynamics in adeno-associated virus capsid assembly.Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 9Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse.Highly divergent integration profile of adeno-associated virus serotype 5 revealed by high-throughput sequencing.Structure of viruses: a short history.Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery VectorsAdeno-associated virus structural biology as a tool in vector development.Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8.Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking.
P2860
Q24533013-90E3E913-76D7-4AF8-841A-4BB8B332981AQ24649385-23438773-E47D-4BF5-8D31-05A6E15978E4Q26782605-3CAE051A-2EC1-43DC-92BA-9F76E15A34E1Q26799552-EA83A887-D122-42BD-909E-07E8173C2859Q27647639-FC97C59C-C1B4-4ACD-81ED-85AB99B7BD15Q27661320-2D223DAD-CE73-4ABA-A06F-267FDDE02748Q27664641-ADB03787-0177-4B8D-A7DA-E8D8FF174518Q27678476-29C5A48D-89F4-400D-84C9-C7E9AEA9AF96Q27679454-24AD3C62-893D-4782-A649-A0BEB908CF11Q30152836-FD35A270-671D-43C7-A7FA-5532168EEFB1Q30419813-08E29B6A-84FE-4153-B230-08A7BB52E7EFQ30557598-A195DA17-8C25-4D59-86E0-19F3C594CDE6Q33232270-0128966E-BF1D-4D17-BE79-BF02B02F3442Q33659389-3231D837-25F3-4249-A5CC-FF6296564200Q33724158-D7C98D09-311E-4B5D-BB95-7FDE726A4287Q33730469-005F114F-9400-488D-A520-B952618B34FAQ33930355-607D4F92-5DCA-40B1-A910-B3BD2AEDFE8BQ34302122-54682C03-4465-4D44-925B-83560EFD4A99Q34572922-B17320DA-0975-4710-81DA-35EA4F09CBABQ34619573-2DF6B924-63DE-44C9-BEFD-D77FCDC4555CQ34631983-C6EB8D1A-200F-4903-8226-ECE6BBD07E1DQ35024289-E31FEF67-378E-4FEB-A058-08D70F3475F6Q35140088-488193EF-E262-433F-B41B-B89E09252E08Q35876224-5974B0ED-018D-4FEE-8C17-9F26659370C3Q36009940-733E5402-89CB-4D48-BEA1-FD883DF967C5Q36010098-8900A5EB-2D63-4DBA-925B-55622BDDDFEAQ36097743-77B583D2-7374-4DA0-B38B-DD3B67362380Q36121666-953CE45B-FC7D-43E8-A7C0-F286B9E4D0C7Q36406869-82552DFF-F638-4FE4-926F-8A5FEAE76C9DQ36426499-82189B08-EDFC-4C29-A7AC-D0E1FC10F894Q36673382-85301B5A-3E79-4856-9A63-930BE4BE7A4DQ37250093-E9E76BC8-EAE0-4B5B-B44B-63AF98B7CF43Q37414094-13D598A8-E9BE-47D0-96AB-194AB15D44EEQ37644024-45A5C3C2-6F43-4847-978A-680E214D35CFQ38124416-747519B9-D94F-4E75-AC55-86489EB93D1BQ38187651-F25AA38E-6936-42A1-828F-7E1DD3A4853FQ38188560-14ABD716-F900-4F71-AA71-AFAF812786E5Q39130497-D3F2218C-4D3A-436A-B38E-024B3F872388Q39409371-8A6FB129-D9BB-4D5A-B803-B6623A9D46F9Q39792135-FA1F64C6-85EA-43BB-A131-6E35F628EDA7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Structure of adeno-associated virus serotype 5.
@en
Structure of adeno-associated virus serotype 5.
@nl
type
label
Structure of adeno-associated virus serotype 5.
@en
Structure of adeno-associated virus serotype 5.
@nl
prefLabel
Structure of adeno-associated virus serotype 5.
@en
Structure of adeno-associated virus serotype 5.
@nl
P2093
P2860
P1433
P1476
Structure of adeno-associated virus serotype 5.
@en
P2093
John A Chiorini
Joseph Zabner
Michael Seiler
Norman H Olson
Robert W Walters
Thomas O Moninger
Timothy S Baker
Valorie D Bowman
P2860
P304
P356
10.1128/JVI.78.7.3361-3371.2004
P407
P577
2004-04-01T00:00:00Z